Collegium Pharmaceutical, Inc. (COLL)
Company Info
US19459J1043
19459J104
May 7, 2015
Highlights
$964.60M
$2.34
12.78
$449.50M
$279.06M
$245.27M
$28.39 - $42.29
$42.80
21.84%
13.12
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Collegium Pharmaceutical, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Collegium Pharmaceutical, Inc. had a return of 3.84% year-to-date (YTD) and -6.33% in the last 12 months.
COLL
3.84%
-10.36%
-17.45%
-6.33%
4.46%
N/A
^GSPC (Benchmark)
4.01%
1.13%
9.82%
22.80%
12.93%
11.26%
Monthly Returns
The table below presents the monthly returns of COLL, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 12.11% | 3.84% | |||||||||||
| 2024 | 7.08% | 11.38% | 5.75% | -4.87% | -10.26% | -2.84% | 19.78% | -0.29% | 0.47% | -11.65% | -10.66% | -6.07% | -6.92% |
| 2023 | 21.03% | -5.52% | -9.57% | -3.00% | -5.16% | -2.63% | 5.91% | 2.90% | -4.57% | -2.64% | 17.78% | 20.09% | 32.67% |
| 2022 | -4.44% | 9.08% | 4.57% | -20.92% | -2.98% | 13.44% | -2.99% | 2.27% | -8.87% | 11.99% | 21.91% | 6.08% | 24.20% |
| 2021 | 20.52% | -2.28% | 0.47% | -5.91% | 7.13% | -1.05% | 5.29% | -17.52% | -3.85% | -0.56% | -10.44% | 6.26% | -6.74% |
| 2020 | -2.26% | 18.07% | -31.24% | 26.64% | 6.62% | -20.63% | -9.83% | 20.79% | 9.23% | -14.36% | 3.70% | 8.33% | -2.67% |
| 2019 | -6.76% | 9.87% | -13.93% | -7.99% | -17.37% | 14.25% | -16.58% | 5.56% | -0.86% | 4.53% | 81.08% | -5.29% | 19.86% |
| 2018 | 29.14% | 0.63% | 6.50% | -7.44% | -4.36% | 5.44% | -19.20% | -11.26% | -13.80% | 8.89% | 19.56% | -10.53% | -6.99% |
| 2017 | 8.03% | -21.17% | -24.13% | -2.49% | -16.21% | 52.19% | -4.32% | -16.12% | 4.48% | -1.53% | 67.09% | 6.95% | 18.56% |
| 2016 | -38.07% | 2.41% | 4.07% | 5.01% | -12.28% | -29.13% | 2.36% | -31.33% | 131.21% | -22.27% | 10.62% | -5.98% | -43.38% |
| 2015 | 38.32% | 4.94% | 12.28% | -24.51% | 46.23% | -16.92% | 3.38% | 44.81% | 123.76% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of COLL is 33, indicating average performance compared to other stocks on our website. Here’s a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Collegium Pharmaceutical, Inc. (COLL) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Worst Drawdowns
The table below displays the maximum drawdowns of the Collegium Pharmaceutical, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Collegium Pharmaceutical, Inc. was 73.59%, occurring on May 8, 2017. Recovery took 210 trading sessions.
The current Collegium Pharmaceutical, Inc. drawdown is 28.93%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -73.59% | Dec 31, 2015 | 340 | May 8, 2017 | 210 | Mar 8, 2018 | 550 |
| -65.22% | Mar 9, 2018 | 344 | Jul 22, 2019 | 890 | Feb 1, 2023 | 1234 |
| -35.05% | Aug 3, 2015 | 22 | Sep 1, 2015 | 9 | Sep 16, 2015 | 31 |
| -33.28% | Sep 21, 2015 | 27 | Oct 27, 2015 | 33 | Dec 14, 2015 | 60 |
| -31.65% | Oct 7, 2024 | 59 | Dec 30, 2024 | — | — | — |
Volatility
Volatility Chart
The current Collegium Pharmaceutical, Inc. volatility is 9.99%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Valuation
The Valuation section provides an assessment of the market value of Collegium Pharmaceutical, Inc. compared to its peers in the Drug Manufacturers - Specialty & Generic industry.
PE Ratio
The chart displays the price to earnings (P/E) ratio for COLL in comparison to other companies of the Drug Manufacturers - Specialty & Generic industry. Currently, COLL has a PE value of 12.8. This PE ratio falls in the average range for the industry.PEG Ratio
The chart displays the price to earnings to growth (PEG) ratio for COLL in comparison to other companies of the Drug Manufacturers - Specialty & Generic industry. Currently, COLL has a PEG value of 0.0. This PEG ratio falls in the average range for the industry.Historical P/E Ratio Chart
The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Collegium Pharmaceutical, Inc..
Loading data...
Income Statement
| TTM | |
|---|---|
Revenue | |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |